Cybin Inc. Common Shares CYBN 深 沪
已收盘 09-18 16:00:00 美东时间
0.204
+0.004
+2.05%
华盛通- 最 高0.204
- 今 开0.2011
- 成交量 354.76万股
- 最 低 0.19
- 昨 收 0.1999
- 总市值 1.55亿
- 52周最高 0.738
- 市盈率 静 --
- 换手率 0.47%
- 52周最低 0.1739
- 委 比 -99.34%
- 总股本 7.60亿
- 历史最高 3.22
- 量 比 0.97
- 振 幅 7.00%
- 历史最低 0.1739
- 每 手 1
- 风险率 0.10%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Catalyst Watch: FOMC, FedEx earnings, Electronic Arts event, and triple witching day
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Seeking Alpha's earnings calendar for a full list of companies due to report....
09-14 03:00
Cybin Inc. Shareholders Approve Key Decisions
Cybin (TSE:CYBN) has released an update. Cybin Inc., a neuropsychiatry company,...
08-28 07:37
Medical journal retracts three articles related to MDMA for PTSD
The journal Psychopharmacology on Aug. 10 retracted three articles related to the use of MDMA for PTSD, the day after the U.S. FDA rejected the use of the psychedlic drug for the condition. Scientists...
08-12 23:50
Cybin Inc. Advances Neuropsychiatric Drug Development
Cybin (TSE:CYBN) has released an update. Cybin Inc., a clinical-stage neuropsyc...
08-08 20:23
Cybin reports Q1 results
Cybin press release (NYSE:CYBN): Q1 Net loss was C$15 million More on Cybin Psychedelic stocks fall as FDA panel rejects MDMA therapy FDA advisory panel fails to endorse psychedelic MDMA therapy for...
08-08 19:58
Cantor Fitzgerald Reiterates Overweight on Cybin
Cantor Fitzgerald analyst Charles Duncan reiterates Cybin (AMEX:CYBN) with a Overweight.
06-22 00:28
Cybin Inc. Welcomes New Clinical Development VP
Cybin (TSE:CYBN) has released an update. Cybin Inc., a biopharmaceutical compan...
06-11 20:10
HC Wainwright & Co.：重申Cybin(CYBN.US)评级，由买入调整至买入评级, 目标价5.00美元。
HC Wainwright & Co.：重申Cybin(CYBN.US)评级，由买入调整至买入评级, 目标价5.00美元。
05-17 01:10
"FDA Expert Committee Will Review MDMA-Assisted Therapy For PTSD Next Month" - Marijuana Moment
https://www.marijuanamoment.net/fda-expert-committee-will-review-mdma-assisted-therapy-for-ptsd-next-month/The Food and Drug Administration (FDA) is taking the next step in its historic review of MDMA-assisted therapy
05-07 23:54
